Completed

Effects of Dynorphin 1-13 on Heroin Addiction

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Data Collection

Who is being recruted

Narcotic-Related Disorders+7

+ Behavior

+ Mental Disorders

From 18 to 55 Years
See all eligibility criteria
How is the trial designed

Treatment Study

Phase 2
Interventional
Study Start: August 1994
See protocol details

Summary

Principal SponsorUniversity of Minnesota
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: August 1, 1994

Actual date on which the first participant was enrolled.

Randomized double blinded study of the effects of a single IV dose of dynorphin A 1-13 on heroin withdrawal in human opiate addicts

Official TitleEffects of Dynorphin 1-13 on Heroin Addiction
NCT00000244
Principal SponsorUniversity of Minnesota
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 55 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Narcotic-Related DisordersBehaviorMental DisordersCompulsive BehaviorImpulsive BehaviorOpioid-Related DisordersSubstance Withdrawal SyndromeBehavior, AddictiveSubstance-Related DisordersChemically-Induced Disorders

Criteria

Inclusion Criteria: opiate addict between the ages of 18-55 Exclusion Criteria: Regular abuse of other drugs, unstable medical conditions

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

U of Minnesota School of Medicine

Minneapolis, United StatesOpen U of Minnesota School of Medicine in Google Maps
CompletedOne Study Center